Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses

International Journal of Antimicrobial Agents

Volumn 35, Issue 3, 2010, Pages 301-304

  Martin Canal, G ^a   Saavedra, A ^a   Asensi, J M ^a   Suarez Zarracina, T ^a   Rodriguez Guardado, A ^a   Bustillo, E ^a   Fierer, J ^b   Carton, J A ^a   Collazos, J ^c   Asensi, V ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Brain abscess; Carbapenems; Meropenem; Neurosurgery; Seizures; Therapy

Indexed keywords

CEFOTAXIME; IMIPENEM; MEROPENEM; METRONIDAZOLE;

ABSCESS DRAINAGE; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN ABSCESS; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; CRANIOTOMY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MONOTHERAPY; MORTALITY; NEUROSURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEIZURE; SURVIVAL RATE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRAIN ABSCESS; FEMALE; HUMANS; IMIPENEM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THIENAMYCINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73549088036     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.11.012     Document Type: Article

References (15)

1. Mathisen G.E., and Johnson J.P. Brain abscess. Clin Infect Dis 25 (1997) 763-769
2. Tseng J.H., and Tseng M.Y. Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol 65 (2006) 557-562
3. Carpenter J., Stapleton S., and Holliman R. Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis 26 (2007) 1-11
4. Sjölin J., Lilja A., Eriksson N., Arneborn P., and Cars O. Treatment of brain abscess with cefotaxime and metronidazole: prospective study on 15 consecutive patients. Clin Infect Dis 17 (1993) 857-863
5. Jansson A.K., Enblad P., and Sjölin J. Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis 23 (2004) 7-14
6. Carton J.A., Perez F., Maradona J.A., and Mendez F.J. Successful treatment of recurrent cerebral empyema and brain abscesses with imipenem. Eur J Clin Microbiol 6 (1987) 578-580
7. Meis J.F., Groot-Loonen J., and Hoogkamp-Korstanje J.A. A brain abscess due to multiple-resistant Enterobacter cloacae successfully treated with meropenem. Clin Infect Dis 20 (1995) 1567
8. Asensi V., Carton J.A., Maradona J.A., Asensi J.M., Pérez F., Redondo P., et al. Imipenem therapy of brain abscess. Eur J Clin Microbiol Infect Dis 15 (1996) 653-657
9. Modai J., Vittecoq D., Decazes J.M., and Meulemans A. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis. J Antimicrob Chemother 16 (1985) 751-755
10. Asensi V., Carton J.A., Maradona J.A., Asensi J.M., Pérez F., Redondo P., et al. Therapy of brain abscess with imipenem-a safe therapeutic choice?. J Antimicrob Chemother 37 (1996) 200-203
11. Calandra G., Lydick E., Carrigan J., Weiss L., and Guess H. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem-cilastatin. Am J Med 84 (1988) 911-918
12. Linden P. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug Saf 30 (2007) 657-668
13. Baldwin C.M., Lyseng-Williamson K.A., and Keam S.J. Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 68 (2008) 803-838
14. Day I.P., Goudie J., Nishiki K., and Williams P.D. Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. Toxicol Lett 76 (1995) 239-243
15. Horiuchi M., Kimura M., Tokumura M., Hasebe N., Arai T., and Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with β-lactam antibiotics. Toxicology 222 (2006) 114-124